Humira Efficacy Response Optimization Study in Subjects With Active Rheumatoid Arthritis (HERO)
Phase of Trial: Phase IV
Latest Information Update: 28 Aug 2007
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Acronyms HERO
- Sponsors Abbott Laboratories
- 28 Aug 2007 Status changed from in progress to completed.
- 20 Dec 2006 Information added from 1057099
- 01 Dec 2005 New trial record.